POLYMED / NSE / Medical Equipment & Supplies
Poly Medicure
1Y Price Trend
Key Information
Recommendations
RatingHold
Target High2,318.35
Target Low1,184
Target Mean2.6
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk49.11
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Poly Medicure Limited investor meet scheduled on June 8 scanx.trade
Indranil Mukherjee Takes Charge as Poly Medicure CEO for Asia Pacific & India Digital Health News
Poly Medicure Ltd is Rated Sell Markets Mojo
Poly Medicure Appoints Indranil Mukherjee as CEO – APAC & India hrtoday.in
Indranil Mukherjee appointed as CEO, Asia Pacific and India, Poly Medicure Medical Buyer
Poly Medicure appoints Indranil Mukherjee as CEO for Asia Pacific and India scanx.trade
Cost advantage alone can’t sustain India’s medtech rise | Hindustan Times Hindustan Times
Poly Medicure targets 20% FY27 growth as it expands high-tech device portfolio CNBC TV18
© SharekeyX | Rusaka Technologies 2024-2026

